Pembrolizumab Monotherapy <i>Versus</i> Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

导出 OA

翻译打印收藏纠错

作者： Mioko,Matsuo ^[1] ; Muneyuki,Masuda ^[2] ; Moriyasu,Yamauchi ^[3] ; Masahiko,Taura ^[4] ; Kazuki,Hashimoto ^[5] ; Ryunosuke,Kogo ^[5] ; Rina,Jiromaru ^[5] ; Takahiro,Hongo ^[5] ; Tomomi,Manako ^[5] ; Takashi,Nakagawa ^[5]

作者单位： Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; matsuo.mioko.202@m.kyushu-u.ac.jp. ^[1] Department of Head and Neck Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan. ^[2] Department of Otolaryngology, Head & Neck Surgery, Saga University Faculty of Medicine, Saga, Japan. ^[3] Department of Otolaryngology Fukuoka University School of Medicine, Fukuoka, Japan. ^[4] Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ^[5]

关键词 Chemotherapy R/M-HNSCC combination therapy long-term prognosis pembrolizumab pembrolizumab monotherapy recurrent and metastatic head and neck squamous cell carcinoma

主题词人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);头颈部肿瘤(Head and Neck Neoplasms);癌, 鳞状细胞(Carcinoma, Squamous Cell);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols)

DOI 10.21873/invivo.13318

PMID 37652513

发布时间 2023-11-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

In vivo (Athens, Greece)

2188-2196页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pembrolizumab Monotherapy <i>Versus</i> Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pembrolizumab Monotherapy <i>Versus</i> Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma.

In vivo (Athens, Greece)

相似文献

In vivo (Athens, Greece)

相关期刊

检索历史清除